Published in Br J Haematol on November 01, 1982
An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet (1977) 7.89
A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut (1973) 6.09
The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol (1972) 6.07
Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J (1970) 4.31
Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet (1974) 4.06
FM1-43 dye behaves as a permeant blocker of the hair-cell mechanotransducer channel. J Neurosci (2001) 3.79
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. Br Med J (1979) 3.56
Transit times of food in patients with diverticulosis or irritable colon syndrome and normal subjects. Br Med J (1967) 3.51
Prevalence of colonic diverticulosis in general population of Oxford area. Br Med J (1967) 3.44
Course and prognosis of Crohn's disease. Gut (1976) 3.02
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut (1980) 2.81
Gastric ulcer and gastritis. Gut (1971) 2.58
A whole-body counter for clinical measurements utilizing the 'shadow shield' technique. Phys Med Biol (1966) 2.51
Effect of Desferrioxamine and D.T.P.A. in Iron Overload. Br Med J (1962) 2.47
The use of a simple whole-body counter for haematological investigations. Br J Haematol (1966) 2.45
Gastric cancer simulating benign gastric ulcer. Br J Surg (1969) 2.27
Auto-immune reactions in ulcerative colitis. Gut (1966) 2.26
Further experience in the treatment of severe attacks of ulcerative colitis. Lancet (1978) 2.25
Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J (1974) 2.24
Irregular Haemagglutinins after Transfusion. Br Med J (1946) 2.18
Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut (1979) 2.08
Do calcium channel blockers and antimuscarinics protect against perforated colonic diverticular disease? A case control study. Gut (2003) 2.05
Jejunal mucosal recovery in coeliac disease in relation to the degree of adherence to a gluten-free diet. Q J Med (1974) 1.95
Ulcerative colitis and pregnancy. Gut (1980) 1.90
The histological classification of duodenitis in fibreoptic biopsy specimens. Digestion (1975) 1.89
Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure. Lancet (1974) 1.80
Crohn's disease and carcinoma of colon. Br Med J (1968) 1.77
Abnormalities in the apparently normal bowel mucosa in Crohn's disease. Lancet (1976) 1.77
Treatment of menorrhagia with tranexamic acid. A double-blind trial. Br Med J (1970) 1.70
Iron absorption and loading in beta-thalassaemia intermedia. Lancet (1979) 1.66
Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis. Gut (1982) 1.60
Measurement of blood loss by means of a whole-body counter. Br Med J (1967) 1.56
Gastroscopy with biopsy and cytological sampling under direct vision. Br Med J (1968) 1.53
Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man? Br Med J (1978) 1.49
Disaccharidase activity and jejunal morphology in coeliac disease. Q J Med (1972) 1.48
Iron absorption and blood loss in patients with hiatus hernia. Br Med J (1968) 1.48
Prevention of iron loading in transfusion-dependent thalassaemia. Lancet (1978) 1.47
The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis. Scand J Gastroenterol (1980) 1.46
Hypolactasia and the irritable colon syndrome. Scand J Gastroenterol (1972) 1.42
The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol (1982) 1.40
Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis. Lancet (1979) 1.40
Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine. Clin Exp Immunol (1974) 1.39
Calcium-hydrogen exchange by the plasma membrane Ca-ATPase of voltage-clamped snail neurons. Proc Biol Sci (1993) 1.33
How frequently do large bowel diverticula perforate? An incidence and cross-sectional study. Eur J Gastroenterol Hepatol (2000) 1.32
Circulating and tissue eosinophils in ulcerative colitis. Am J Dig Dis (1966) 1.32
Epidemiology of perforated colonic diverticular disease. Postgrad Med J (2002) 1.32
A follow-up study of patients with post-cricoid webs. Q J Med (1971) 1.31
Lack of harmful effect of oats on small-intestinal mucosa in coeliac disease. Br Med J (1974) 1.31
Stimulation of lymphocytes from patients with coeliac disease by a subfraction of gluten. Lancet (1976) 1.31
Propulsion and retropulsion of normal colonic contents. Am J Dig Dis (1971) 1.30
The timing of histological damage following a single challenge with gluten in treated coeliac disease. Q J Med (1981) 1.29
Iron absorption from bread. Am J Clin Nutr (1968) 1.29
Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload. Q J Med (1979) 1.28
Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial. Br Med J (1972) 1.28
The liver in ulcerative colitis. Q J Med (1971) 1.27
Glucosamine synthetase activity of the colonic mucosa in ulcerative colitis and Crohn's disease. Gut (1977) 1.26
Insulin targeting to the regulated secretory pathway after fusion with green fluorescent protein and firefly luciferase. Biochem J (1998) 1.26
The role of propranolol in congestive gastropathy of portal hypertension. Hepatology (1987) 1.26
Gastritis duodenitis, and circulating levels of gastrin in duodenal ulcer before and after vagotomy. Gut (1976) 1.25
Cerebral venous thrombosis as a complication of ulcerative colitis. Am J Dig Dis (1967) 1.25
Possible association between pernicious anaemia and leukaemia: a prospective study of 1,625 patients with a note on the very high incidence of stomach cancer. Int J Cancer (1968) 1.20
Comparison of various treatments for irritable bowel syndrome. Br Med J (1980) 1.20
The role of various cereals in coeliac disease. Q J Med (1978) 1.19
Glucose-dependent translocation of insulin promoter factor-1 (IPF-1) between the nuclear periphery and the nucleoplasm of single MIN6 beta-cells. J Biol Chem (1998) 1.18
The liver in Crohn's disease. Q J Med (1971) 1.16
Circulating antibodies to cow's milk proteins in ulcerative colitis. Gut (1972) 1.16
Identifying toxic fractions of wheat gluten and their effect on the jejunal mucosa in coeliac disease. Gut (1974) 1.13
Proctocolectomy for ulcerative colitis. World J Surg (1980) 1.12
Campylobacter colitis. J Clin Pathol (1979) 1.12
Intensive intravenous regimen for membranous colitis. Br Med J (1976) 1.11
Tissue eosinophils in ulcerative colitis. Scand J Gastroenterol (1979) 1.10
Iron deficiency and autoimmunity in post-cricoid webs. Q J Med (1971) 1.10
Anti-inflammatory drugs, analgesics and the risk of perforated colonic diverticular disease. Br J Surg (2003) 1.10
The management of ulcerative colitis. Br J Clin Pract (1974) 1.07
Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey. Gut (1983) 1.06
Ferrioxamine excretion in iron-loaded man. Blood (1982) 1.06
Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis. Gut (1980) 1.06
Luminal ions and short chain fatty acids as markers of functional activity of the mucosa in ulcerative colitis. J Clin Pathol (1982) 1.05
Water and electrolyte balance in subjects with a permanent ileostomy. Gut (1983) 1.05
Placental and mammary transfer of sulphasalazine. Br Med J (1979) 1.04
The effects of prednisolone in leucocyte function in man. A double blind controlled study. Clin Exp Immunol (1977) 1.04
Movements of the large intestine. Physiol Rev (1966) 1.04
The health of subjects living with a permanent ileostomy. Q J Med (1982) 1.04
Skin test for coeliac disease using a subfraction of gluten. Lancet (1977) 1.04
The patterns of fetal haemoglobin production in leukaemia. Br J Haematol (1976) 1.02
Segmentation and the localization of intraluminal pressure in the human colon, with special reference to the pathogenesis of colonic diverticula. Gastroenterology (1968) 1.01
Absorption of therapeutic preparations of iron measured with a whole body counter. Br Med J (1969) 1.01
Real-time imaging of gene expression in single living cells. Chem Biol (1998) 1.00
Possible function of different renal metabolites of vitamin D in man. Contrib Nephrol (1980) 1.00